A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus

Name: A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus
Published: 2016
License: Public Domain

AbbVie · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

respiratory syncytial virus (rsv), bronchopulmonary dysplasia (bpd), rsv hospitalization, palivizumab, immunoprophylaxis, chronic lung disease (cld) of prematurity, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus

Related documents